“Growing Adoption of Advanced OCT Imaging Technologies”
A key trend driving growth in the bilateral cystoid macular edema (CME) market is the increasing adoption of advanced Optical Coherence Tomography (OCT) imaging technologies. These technologies enable detailed visualization of retinal layers, aiding early detection and monitoring of CME. This advancement facilitates tailored treatment approaches, improving patient outcomes. For instance, the introduction of Swept-Source OCT, which provides deeper and faster retinal imaging, has gained traction among ophthalmologists. Companies such as Carl Zeiss Meditec and Heidelberg Engineering are expanding their product offerings in this domain, fueling market growth. The improved diagnostic accuracy offered by these technologies is enhancing therapeutic strategies and driving their demand globally.
